Sign In

Login

Password

Forgot Password ? Sign Up

Buspiron (Serbian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Buspiron" in Serbian language version.

refsWebsite
Global rank Serbian rank
4nih.gov
4th place
8th place
2doi.org
2nd place
4th place
1drugs.com
399th place
744th place
1web.archive.org
1st place
1st place
1espacenet.com
800th place
905th place

doi.org

  • Trivedi MH, Fava M, Wisniewski SR, Thase ME, Quitkin F, Warden D, Ritz L, Nierenberg AA, Lebowitz BD, Biggs MM, Luther JF, Shores-Wilson K, Rush AJ (2006). „Medication augmentation after the failure of SSRIs for depression”. N. Engl. J. Med. 354 (12): 1243—52. PMID 16554526. doi:10.1056/NEJMoa052964. 
  • Wu YH, Rayburn JW, Allen LE, Ferguson HC, Kissel JW (1972). „Psychosedative agents. 2. 8-(4-Substituted 1-piperazinylalkyl)-8-azaspiro(4.5)decane-7,9-diones”. J. Med. Chem. 15 (5): 477—9. PMID 5035267. doi:10.1021/jm00275a009. ;
    DE 2057845, Rayburn JW, Wu YH, "Heterocyclische Azaspirodecandione und Verfahren zu ihrer Herstellung", published 9. 6. 1971. ;
    US 3717634, Rayburn JW, Wu YH, "N-(heteroarcyclic)piperazinylalkyl-azaspiroalkanediones", published 20. 2. 1973. ;
    US 3907801, Rayburn JW, Wu YH, "N8 (4-pyridyl-piperazino)-alkyl9-azaspiroalkanediones", published 23. 9. 1975. ;
    US 3976776, Rayburn JW, Wu YH, "Tranquilizer process employing N-(heteroarcyclic)piperazinylalkylazaspiroalkanediones", published 24. 8. 1976. 

drugs.com

espacenet.com

worldwide.espacenet.com

  • Wu YH, Rayburn JW, Allen LE, Ferguson HC, Kissel JW (1972). „Psychosedative agents. 2. 8-(4-Substituted 1-piperazinylalkyl)-8-azaspiro(4.5)decane-7,9-diones”. J. Med. Chem. 15 (5): 477—9. PMID 5035267. doi:10.1021/jm00275a009. ;
    DE 2057845, Rayburn JW, Wu YH, "Heterocyclische Azaspirodecandione und Verfahren zu ihrer Herstellung", published 9. 6. 1971. ;
    US 3717634, Rayburn JW, Wu YH, "N-(heteroarcyclic)piperazinylalkyl-azaspiroalkanediones", published 20. 2. 1973. ;
    US 3907801, Rayburn JW, Wu YH, "N8 (4-pyridyl-piperazino)-alkyl9-azaspiroalkanediones", published 23. 9. 1975. ;
    US 3976776, Rayburn JW, Wu YH, "Tranquilizer process employing N-(heteroarcyclic)piperazinylalkylazaspiroalkanediones", published 24. 8. 1976. 

nih.gov

ncbi.nlm.nih.gov

  • Trivedi MH, Fava M, Wisniewski SR, Thase ME, Quitkin F, Warden D, Ritz L, Nierenberg AA, Lebowitz BD, Biggs MM, Luther JF, Shores-Wilson K, Rush AJ (2006). „Medication augmentation after the failure of SSRIs for depression”. N. Engl. J. Med. 354 (12): 1243—52. PMID 16554526. doi:10.1056/NEJMoa052964. 
  • Appelberg BG, Syvälahti EK, Koskinen TE, Mehtonen OP, Muhonen TT, Naukkarinen HH (2001). „Patients with severe depression may benefit from buspirone augmentation of selective serotonin reuptake inhibitors and in a Class of Drugs called Benzodiazepines and effects similar if not idenical to Alprazelam,Lorazepam etc : results from a placebo-controlled, randomized, double-blind, placebo wash-in study”. J Clin Psychiatry. 62 (6): 448—52. PMID 11465522. 
  • Wu YH, Rayburn JW, Allen LE, Ferguson HC, Kissel JW (1972). „Psychosedative agents. 2. 8-(4-Substituted 1-piperazinylalkyl)-8-azaspiro(4.5)decane-7,9-diones”. J. Med. Chem. 15 (5): 477—9. PMID 5035267. doi:10.1021/jm00275a009. ;
    DE 2057845, Rayburn JW, Wu YH, "Heterocyclische Azaspirodecandione und Verfahren zu ihrer Herstellung", published 9. 6. 1971. ;
    US 3717634, Rayburn JW, Wu YH, "N-(heteroarcyclic)piperazinylalkyl-azaspiroalkanediones", published 20. 2. 1973. ;
    US 3907801, Rayburn JW, Wu YH, "N8 (4-pyridyl-piperazino)-alkyl9-azaspiroalkanediones", published 23. 9. 1975. ;
    US 3976776, Rayburn JW, Wu YH, "Tranquilizer process employing N-(heteroarcyclic)piperazinylalkylazaspiroalkanediones", published 24. 8. 1976. 

nimh.nih.gov

web.archive.org